GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 124 filers reported holding GOSSAMER BIO INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $35,323 | +12.1% | 29,935 | -13.3% | 0.00% | – |
| Q4 2023 | $31,521 | +13.0% | 34,543 | +3.1% | 0.00% | – |
| Q3 2023 | $27,902 | -30.6% | 33,504 | 0.0% | 0.00% | – |
| Q2 2023 | $40,205 | +50.9% | 33,504 | +58.4% | 0.00% | – |
| Q1 2023 | $26,650 | -45.5% | 21,151 | -6.1% | 0.00% | – |
| Q4 2022 | $48,868 | -77.4% | 22,520 | +25.0% | 0.00% | – |
| Q3 2022 | $216,000 | +40.3% | 18,009 | -1.9% | 0.00% | – |
| Q2 2022 | $154,000 | -18.5% | 18,351 | +22.3% | 0.00% | – |
| Q3 2021 | $189,000 | +33.1% | 15,001 | -14.0% | 0.00% | – |
| Q2 2021 | $142,000 | -9.0% | 17,436 | +3.5% | 0.00% | – |
| Q1 2021 | $156,000 | +3.3% | 16,850 | +7.6% | 0.00% | – |
| Q4 2020 | $151,000 | -9.6% | 15,665 | +16.6% | 0.00% | – |
| Q3 2020 | $167,000 | -8.7% | 13,436 | -4.7% | 0.00% | – |
| Q2 2020 | $183,000 | +77.7% | 14,100 | +38.5% | 0.00% | – |
| Q1 2020 | $103,000 | – | 10,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |